Compare VERA & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | ERO |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2021 | 2021 |
| Metric | VERA | ERO |
|---|---|---|
| Price | $35.05 | $35.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $81.30 | $36.50 |
| AVG Volume (30 Days) | ★ 1.8M | 1.5M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $51.94 |
| Revenue Next Year | $472.48 | $2.43 |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.72 | $16.37 |
| 52 Week High | $56.05 | $40.83 |
| Indicator | VERA | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 49.98 |
| Support Level | $29.66 | $24.04 |
| Resistance Level | $37.13 | $36.25 |
| Average True Range (ATR) | 1.70 | 1.83 |
| MACD | 0.12 | -0.50 |
| Stochastic Oscillator | 38.42 | 11.75 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Ero Copper Corp is a high-margin, high-growth copper producer with operations in Brazil. Its primary asset is its 99.6% ownership interest in Mineracao Caraiba S.A., held indirectly through its wholly-owned subsidiary. The company also owns a 97.6% ownership interest in NX Gold S.A. indirectly through its wholly-owned subsidiary. Its reporting segments include its three operating mines in Brazil, the Caraiba Operations, the Tucuma Operation, and the Xavantina Operations, and its corporate head office in Canada.